Effects of topically administered neuroprotective drugs in early stages of diabetic retinopathy. Results of the EUROCONDOR clinical trial

Rafael Simó*, Cristina Hernández, Massimo Porta, Francesco Bandello, Jakob Grauslund, Simon P. Harding, Stephen J. Aldington, Catherine Egan, Ulrik Frydkjaer-Olsen, José García-Arumí, Jonathan Gibson, Gabriele E. Lang, Rosangela Lattanzio, Pascale Massin, Edoardo Midena, Berta Ponsati, Luísa Ribeiro, Peter Scanlon, Miguel Ângelo Costa, and José Cunha-Vaz*, for the European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR)

Diabetes. 2018 Nov 2. pii: db180682. doi: 10.2337/db18-0682.

2018